(Q44547739)

English

Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial

scientific article published in July 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

neurocysticercosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Veena Kalra

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Tarun Dua

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Virender Kumar

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

The Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

143

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

111-114

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Focal epilepsy in India with special reference to lesions showing ring or disc-like enhancement on contrast computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Vanishing CT lesions in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Single ring- or disk-enhancing computed tomographic lesion in Indian children and adolescents after first seizure

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Cysticercosis and epilepsy: a critical review.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Differentiating solitary small cysticercus granulomas and tuberculomas in patients with epilepsy. Clinical and computerized tomographic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Clinicoradiological and pathological correlations in patients with solitary cysticercus granuloma and epilepsy: focus on presence of the parasite and oedema formation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Is the course of neurocysticercosis modified by treatment with antihelminthic agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Spontaneous radiographic disappearance of cerebral cysticercosis: three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Single-enhancing CT lesions in Indian patients with seizures: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Therapy for neurocysticercosis. Comparison between albendazole and praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

The course of seizures after treatment for cerebral cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Albendazole in single CT ring lesions in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Treating neurocysticercosis medically: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2803%2900211-7

7 January 2021

Identifiers

10.1016/S0022-3476(03)00211-7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44547739&oldid=2215555139"